Current CEO and Tenure
As of 2025, the chief executive officer of HCA Healthcare is Sam Hazen. Hazen has served in this role since September 1, 2023, following the retirement of predecessor Richard Bracken. He previously held the role of HCA’s president and chief operating officer, and earlier served as group president of HCA’s West region. Hazen is a member of the company’s board of directors and represents management on the board’s executive and compensation committees.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Name | Sam Hazen | HCA Investor Relations / SEC filings |
| CEO Start Date | September 1, 2023 | Company announcement |
| Previous Title | President and COO | Corporate bio |
Executive Background and Career Path
Sam Hazen’s career at HCA spans more than two decades. He joined the organization in 2001 and has held a series of progressively responsible roles in finance, strategy, and operations. Prior to becoming CEO, he led major hospital groups, managed enterprise service functions, and played a key role in post-merger integrations and performance improvement initiatives. His deep institutional knowledge is frequently cited by the board as a reason for his selection as successor to long-term CEO Richard Bracken.
CEO’s Strategic Leadership Priorities
Since taking over, Hazen has emphasized disciplined capital allocation, margin expansion, and measured investment in ambulatory and digital services. Public statements and investor materials highlight three recurring themes:
- Operational excellence and cost discipline: Optimizing staffing, supply chain, and facility utilization across a large, multi-state footprint.
- Strategic acquisitions and partnerships: Selective expansion in high-growth markets and service lines, including post-accretion integration and value realization.
- Long-term value and governance: Reinvesting in infrastructure, technology, and compliance while maintaining a strong balance sheet and conservative credit metrics.
Role in Governance and Board Relations
As both a manager and a director, Hazen participates in setting oversight priorities, reviewing major risk and compliance frameworks, and aligning executive incentives with long-term shareholder interests. In board meetings, he provides management perspective on enterprise risk, capital planning, and regulatory matters, including ESG-related disclosures, cybersecurity, and privacy. This dual accountability—answering to the board while leading the business—is central to the modern governance model at HCA.
Corporate Context and Market Position
HCA Healthcare operates one of the largest networks of acute-care hospitals and surgery centers in the United States, with a presence in multiple states and a growing presence in outpatient services. The company competes on service volume, quality outcomes, and operational efficiency. Understanding Hazen’s stewardship is best done in this context: a large, complex healthcare system in a regulated, capital-intensive industry where execution consistency and risk management are paramount.
| Metric | Estimate or Range | Context |
|---|---|---|
| Approximate Total Hospitals | ~200 | Company annual report disclosures |
| Approximate Licensed Beds | ~130,000 | Public filings and investor slides |
| Geographic Footprint | Multiple U.S. regions | Operational summaries |
Compensation and Shareholder Alignment
Details of Hazen’s total compensation—including base salary, short- and long-term incentives, and equity awards—are disclosed in HCA’s proxy statements (DEF 14A). While exact pay figures fluctuate with performance and market conditions, the structure is designed to align managerial decisions with long-term enterprise value. Key components typically include cash targets, stock-based awards tied to multi-year performance metrics, and strict governance around risk and compliance adherence.
Succession Planning and Leadership Continuity
Boards of large healthcare systems place high importance on orderly succession. Hazen’s appointment followed a planned transition, allowing for continuity in clinical operations, payer relationships, and regulatory engagement. Public governance documents indicate that the board evaluates executive tenure, capability, and bench depth on a regular cycle, reducing disruption risk and supporting stable strategic execution.
Key Takeaways
- Sam Hazen is the current CEO of HCA Healthcare as of 2025.
- He became CEO on September 1, 2023, after serving as president and chief operating officer.
- His leadership emphasizes operational efficiency, selective growth, and strong governance.
- He represents management on the board and is accountable to both the board and shareholders.
- Compensation is aligned with long-term performance, disclosed in proxy materials.
Reliable Sources and Further Reading
For ongoing verification, refer to HCA’s investor relations materials, annual reports (10-K), proxy statements (DEF 14A), and official press releases on executive appointments. These documents provide structured, auditable details about tenure, governance responsibilities, and performance context.